The impact of co‐existing immune‐mediated diseases on phenotype and outcomes in inflammatory bowel diseases

Abstract

The presence of another immune-mediated disease in IBD patients was associated with higher likelihood of pancolonic involvement in UC, and a modest increase in need for IBD-related surgery and anti-TNF biological therapy. Such patients also experienced worse quality of life.